Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans

Streptozotocin (STZ) (2-deoxy-2-({[methyl(nitroso)amino]carbonyl}amino)-β-D-glucopyranose) is a naturally occurring diabetogenic compound, produced by the soil bacterium streptomyces achromogenes , that exhibits broad spectrum of antibacterial properties. Streptozotocin functions as a DNA synthesis...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes and metabolic disorders 2013-12, Vol.12 (1), p.60-60, Article 60
Main Authors: Eleazu, Chinedum Ogbonnaya, Eleazu, Kate Chinedum, Chukwuma, Sonia, Essien, Udeme Nelson
Format: Article
Language:English
Subjects:
Diabetes
Endocrinology
Medicine & Public Health
Metabolic Diseases
Review
Review Article
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Streptozotocin (STZ) (2-deoxy-2-({[methyl(nitroso)amino]carbonyl}amino)-β-D-glucopyranose) is a naturally occurring diabetogenic compound, produced by the soil bacterium streptomyces achromogenes , that exhibits broad spectrum of antibacterial properties. Streptozotocin functions as a DNA synthesis inhibitor in both bacterial and mammalian cells. In mammalian cells, the actual mechanism and metabolic targets of STZ toxicity that results in cell death is not known. This review identifies four key areas that explain the mechanism of the cytotoxicity of STZ in mammalian cell lines, investigates the practical aspects of using STZ in experimental animals and the potential risks of its exposure to human health.
ISSN:2251-6581
2251-6581
DOI:10.1186/2251-6581-12-60